v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating Expenses:        
Research and development $ 22,882 $ 16,879 $ 46,225 $ 33,932
General and administrative [1] 5,731 5,883 11,423 11,145
Total operating expenses 28,613 22,762 57,648 45,077
Total operating loss (28,613) (22,762) (57,648) (45,077)
Other income (expense):        
Interest income, including amortization and accretion income 1,678 2,451 3,271 5,137
Other expense (36) (26) (59) (57)
Total other income 1,642 2,425 3,212 5,080
Loss before income taxes (26,971) (20,337) (54,436) (39,997)
Income tax provision, net (48)   (66) (46)
Net loss $ (27,019) $ (20,337) $ (54,502) $ (40,043)
Net loss per common share - basic $ (0.47) $ (0.41) $ (1.01) $ (0.81)
Net loss per common share - diluted $ (0.47) $ (0.41) $ (1.01) $ (0.81)
Weighted average common stock outstanding - basic 58,015,718 49,548,120 54,092,728 49,500,032
Weighted average common stock outstanding - diluted 58,015,718 49,548,120 54,092,728 49,500,032
Comprehensive loss:        
Net loss $ (27,019) $ (20,337) $ (54,502) $ (40,043)
Other comprehensive items:        
Unrealized loss on marketable securities (88) (201) (226) (722)
Currency translation adjustment 8   (12)  
Total other comprehensive loss (80) (201) (238) (722)
Total comprehensive loss $ (27,099) $ (20,538) $ (54,740) $ (40,765)
[1] Includes depreciation expense directly allocated to respective activities.